1887

Abstract

The physical state of the human papillomavirus (HPV) genome is usually different in malignant lesions of the skin, in which it is generally found in episomal form, and genital mucosa, in which it is frequently integrated with disruption of the E2 gene. Using chimeric or natural HPV promoters in the presence of the bovine papillomavirus type 1 E2 gene product, we observed transcription activation or repression, depending on the distance of E2-binding motifs from the start site. We found a clear difference in the positions of E2-binding motifs in cutaneous and genital HPVs that may partly explain the selective pressure for genome integration of genital HPV types in malignant lesions.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-6-1395
1992-06-01
2021-10-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/6/JV0730061395.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-6-1395&mimeType=html&fmt=ahah

References

  1. Androphy E. J., Lowy D. R., Schiller J. T. 1987; Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA. Nature, London 325:70–73
    [Google Scholar]
  2. Baker C. C., Phelps W. C., Lindgren V., Braun M. J., Gonda M. A., Howley P. M. 1987; Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. Journal of Virology 61:962–971
    [Google Scholar]
  3. Bedrosian C. L., Bastia D. 1990; The DNA-binding domain of HPV16-E2 protein interaction with the viral enhancer: protein-induced DNA bending and role of the nonconserved core sequence in binding site affinity. Virology 174:557–575
    [Google Scholar]
  4. Bernard B. A., Bailly C., Lenoir M.-C., Darmon M., Thierry F., Yaniv M. 1989; The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV 18 regulatory region in human keratinocytes. Journal of Virology 63:4317–4324
    [Google Scholar]
  5. Chin M. T., Hirochika R., Hirochika H., Broker T. R., Chow L. T. 1988; Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies. Journal of Virology 62:2994–3002
    [Google Scholar]
  6. Cole S. T., Danos O. 1987; Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products. Journal of Molecular Biology 193:599–608
    [Google Scholar]
  7. Cole S. T., Streeck R. E. 1986; Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer. Journal of Virology 58:991–995
    [Google Scholar]
  8. Cripe T. C., Haugen T. H., Turk J. P., Tabatabai F., Schmid P. G., Dürst M., Gissmann L., Roman A., Turek L. P. 1987; Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis. EMBO Journal 6:3745–3753
    [Google Scholar]
  9. Crum C. P., Mitao M., Levine R. U., Silverstein S. 1985; Cervical papillomaviruses segregate within morphologically distinct precancerous lesions. Journal of Virology 54:675–681
    [Google Scholar]
  10. Danos O., Katinka M., Yaniv M. 1982; Human papillomavirus la complete DNA sequence: a novel type of genome organization among Papovaviridae. EMBO Journal 1:231–236
    [Google Scholar]
  11. Dartmann K., Schwarz E., Gissmann L., zur Hausen H. 1986; The nucleotide sequence and genome organization of human papilloma virus type 11. Virology 151:124–130
    [Google Scholar]
  12. de Villiers E. -M. 1989; Heterogeneity of the human papillomavirus group. Journal of Virology 63:4898–4903
    [Google Scholar]
  13. Dostatni N., Thierry F., Yaniv M. 1988; A dimer of BPV-1 E2 containing a protease resistant core interacts with its DNA target. EMBO Journal 7:3807–3816
    [Google Scholar]
  14. Dürst M., Kleinheinz A., Hotz M., Gissmann L. 1985; The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. Journal of General Virology 66:1515–1522
    [Google Scholar]
  15. Ensser A., Pfister H. 1990; Epidermodysplasia verruciformis associated human papillomaviruses present a subgenus-specific organization of the regulatory genome region. Nucleic Acids Research 18:3919–3922
    [Google Scholar]
  16. Fuchs P. G., Iftner T., Weninger J., Pfister H. 1986; Epidermodysplasia verruciformis-associated human papillomavirus 8: genomic sequence and comparative analysis. Journal of Virology 58:626–634
    [Google Scholar]
  17. Garci-Carranca A., Thierry F., Yaniv M. 1988; Interplay of viral and cellular proteins along the long control region of human papillomavirus type 18. Journal of Virology 62:4321–4330
    [Google Scholar]
  18. Gloss B., Bernard H.-U. 1990; The E6/E7 promoter of human papillomavirus type-16 is activated in the absence of E2 proteins by a sequence-aberrant Spl distal element. Journal of Virology 64:5577–5584
    [Google Scholar]
  19. Herbomel P., Bourachot B., Yaniv M. 1984; Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell 39:653–662
    [Google Scholar]
  20. Hirochika H., Hirochika R., Broker T. R., Chow L. T. 1988; Functional mapping of the human papillomavirus type 11 transcriptional enhancer and its interaction with the trans-acting E2 proteins. Genes & Development 2:54–67
    [Google Scholar]
  21. Kirri Y., Iwamoto S., Matsukura T. 1992; Human papillomavirus type 58 DNA sequence. Virology 185:424–427
    [Google Scholar]
  22. Kiyono T., Adachi A., Ishibashi M. 1990; Genome organization and taxonomic position of human papillomavirus type 47 inferred from its DNA sequence. Virology 177:401–405
    [Google Scholar]
  23. Krubke J., Kraus J., Delius H., Chow L., Broker T., Iftner T., Pfister H. 1987; Genetic relationship among human papillomaviruses associated with benign and malignant tumours of patients with epidermodysplasia verruciformis. Journal of General Virology 68:3091–3103
    [Google Scholar]
  24. Lehn H., Krieg P., Sauer G. 1985; Papillomavirus genomes in human cervical tumors: analysis of their transcriptional activity. Proceedings of the National Academy of Sciences, U.S.A. 82:5540–5544
    [Google Scholar]
  25. McBride A. A., Byrne J. C., Howley P. M. 1989; E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: transactivation is mediated by the conserved amino-terminal domain. Proceedings of the National Academy of Sciences, U.S.A. 86:510–514
    [Google Scholar]
  26. Matsukura T., Kanda T., Furuno A., Yoshikawa H., Kawana T., Yoshiike K. 1986; Cloning of monomeric human papillomavirus type 16 DNA integrated within cell DNA from a cervical carcinoma. Journal of Virology 58:979–982
    [Google Scholar]
  27. Maxam A. M., Gilbert W. 1980; Sequencing end-labeled DNA with base-specific chemical cleavages. Methods in Enzymology 65:499–560
    [Google Scholar]
  28. Münger K., Phelps W. C., Bubb V., Howley P. M., Schlegel R. 1989; The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. Journal of Virology 63:4417–4421
    [Google Scholar]
  29. Orth G. 1987; Epidermodysplasia verruciformis. In The Papovaviridae vol 2 pp 199–235 Edited by Salzman N. P., Howley P. M. New York: Plenum Press;
    [Google Scholar]
  30. Pfister H. 1987; Human papillomaviruses and genital cancer. Advances in Cancer Research 48:113–148
    [Google Scholar]
  31. Phelps W. C., Howley P. M. 1987; Transcriptional transactivation by the human papillomavirus type 16 E2 gene product. Journal of Virology 61:1630–1638
    [Google Scholar]
  32. Romanczuck H., Thierry F., Howley P. M. 1990; Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. Journal of Virology 64:2849–2859
    [Google Scholar]
  33. Schneider-Maunoury S., Croissant O., Orth G. 1987; Integration of human papillomavirus type 16 DNA sequences: a possible early event in the progression of genital tumors. Journal of Virology 61:3295–3298
    [Google Scholar]
  34. Schwarz E., Dürst M., Demenkowski G., Latterman O., Zech R., Wolfsberger E., Suhai S., zur Hausen H. 1983; DNA sequence and genome organization of genital human papillomavirus type 6b. EMBO Journal 2:2341–2348
    [Google Scholar]
  35. Schwarz E., Freese U. K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., zur Hausen H. 1985; Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature, London 314:111–114
    [Google Scholar]
  36. Seedorf K., KrÄmmer G., Dürst M., Suhai S., Rowekamp W. G. 1985; Human papillomavirus type 16 DNA sequence. Virology 145:181–185
    [Google Scholar]
  37. Spalholz B. A., Yang Y. C., Howley P. M. 1985; Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene product. Cell 42:183–191
    [Google Scholar]
  38. Takahashi K., Vigneron M., Matthes H., Wildeman A., Zenke M., Chambon P. 1986; Requirement of stereospecific alignments for initiation from the simian virus 40 early promoter. Nature, London 319:121–126
    [Google Scholar]
  39. Thierry F., Howley P. M. 1991; Functional analysis of E2-mediated repression of the HPV18 P105 promoter. New Biologist 3:90–100
    [Google Scholar]
  40. Thierry F., Yaniv M. 1987; The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region. EMBO Journal 6:3391–3397
    [Google Scholar]
  41. Thierry F., Garca-CarrancÁ A., Yaniv M. 1987; Elements that control the transcription of genital human papillomavirus type 18. Cancer Cells 5:23–32
    [Google Scholar]
  42. Volpers C., Streeck R. E. 1991; Genome organization and nucleotide sequence of human papillomavirus type 39. Virology 181:419–423
    [Google Scholar]
  43. Yee C., Krishnan-Hewlett I., Baker C. C., Schlegel R., Howley P. M. 1985; Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. American Journal of Pathology 119:361–366
    [Google Scholar]
  44. Zachow K. R., Ostrow R. S., Faras A. J. 1987; Nucleotide sequence and genome organization of human papillomavirus type 5. Virology 158:251–254
    [Google Scholar]
  45. zur Hausen H., Schneider A. 1987; The role of papillomaviruses in human anogenital cancers. In The Papovaviridae vol 2 pp 245–263 Edited by Salzman N. P., Howley P. M. New York: Plenum Press;
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-6-1395
Loading
/content/journal/jgv/10.1099/0022-1317-73-6-1395
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error